SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10KSB/A - Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]: [Amend]
SEC Accession No. 0000812796-08-000021
Filing Date
2008-04-29
Accepted
2008-04-29 16:14:14
Documents
5
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 DOR 10 K 2007 dor10k2007.htm 10KSB/A 614076
2 CEO CERT ceocert10k2007.htm EX-31.1 12761
3 CFO CERT cfocert10k2007.htm EX-31.2 12705
4 CEO SOX CERT ceosox10k2007.htm EX-32.1 6622
5 CFO SOX CERT cfosox10k2007.htm EX-32.2 6593
  Complete submission text file 0000812796-08-000021.txt   654374
Mailing Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628
Business Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628 609-538-8200
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10KSB/A | Act: 34 | File No.: 000-16929 | Film No.: 08785657
SIC: 2834 Pharmaceutical Preparations